New drugs and indications in 2012 Sluggish progress, timid measures to protect patients

首页> 外文期刊>Prescrire international >New drugs and indications in 2012 Sluggish progress, timid measures to protect patients

【24h】

New drugs and indications in 2012 Sluggish progress, timid measures to protect patients

机译：2012年的新药和适应症进展缓慢，保护患者的怯tim措施

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The therapeutic advances identified in 2012 were minimal, and 15 new drugs or indications are dangerous. The dearth of improvement in patient care contrasts with the sometimes disproportionately high prices agreed upon for drugs, especially in oncology. The few steps taken by health authorities that benefited patients, mainly by withdrawing or revoking reimbursement for drugs with an unfavourable harm-benefit balance, were insufficient in view of the constant pressure from the pharmaceutical industry to sell ever more drugs.

机译：2012年确定的治疗进展微乎其微，有15种新药或适应症很危险。缺乏患者护理方面的改进与药品，特别是肿瘤学上商定的有时价格不成比例的高价形成对比。鉴于制药行业持续不断地要求出售更多的药物，卫生当局采取的使患者受益的措施主要是通过撤回或取消对损害赔偿金不利的药物来使患者受益。

著录项

来源
《Prescrire international》 |2013年第137期|共3页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. New drugs and indications in 2012 Sluggish progress, timid measures to protect patients [J] . Prescrire international . 2013,第137期

机译：2012年的新药和适应症进展缓慢，保护患者的怯tim措施
2. Performance of the upper limb module for Chinese patients with Duchenne muscular dystrophy: a new useful clinical tool to monitor the disease progress and as an outcome measure for therapeutic drug trial [J] . Chiu Y., Choi W., Hui C., Neuromuscular disorders: NMD . 2017,第Suppla2期

机译：杜南肌营养不良患者上肢模块的性能：一种新的临床工具，用于监测疾病进展，作为治疗药物试验的结果措施
3. Patient based methods for assessing adverse events in clinical trials in rheumatology. Progress report for the OMERACT Drug Toxicity Working Party. Outcome Measures in Rheumatology. [J] . Gazarian M, Tugwell P, Boers M, The Journal of rheumatology . 1999,第1期

机译：基于患者的评估风湿病临床试验不良事件的方法。 OMERACT药物毒性工作组的进度报告。风湿病学中的结果指标。
4. Blockchain and the Protection of Patient Information: Using Blockchain to Protect the Information of Patients in Line with HIPAA (Work-in-Progress) [C] . Colin DeLeon, Young Choi, Jungwoo Ryoo International Conference on Software Security and Assurance . 2018

机译：区块链和患者信息保护：使用区块链保护符合HIPAA（正在进行的工作）的患者信息
5. Reconciling conflicts between trademark and geographical indications: How to protect geographical indications in China. [D] . Huang, Guilin. 2003

机译：调解商标与地理标志之间的冲突：如何保护中国的地理标志。
6. Concerns Over Participant Suicides Prematurely Abort a Clinical Trial of Potentially Significant Impact on Public Health: How Will We Make Progress in Timid Times? [O] . Joseph F. Cubells -1

机译：担忧参与者自杀过早中止对公众健康潜在巨大影响的临床试验：我们将如何胆小时报取得进步？
7. European Public Health News * President's column * EUPHA office column--EUPHA 1992-2012 * Message from the World Health Organization Regional Director for Europe Healthy Ageing in Europe: Empowering More People to Remain Active and Healthy at Higher Ages * European Commission Proposes Measures to Better Protect Europeans from Serious Cross-border Threats to Health * Malta 2012 5th Annual European Public Health Conference 2012: All Inclusive Public Health, Portomaso, St Julian's, Malta, 8-10 November 2012 [O] . D. Zeegers Paget, W. Ricciardi, Z. Jakab, 2012

机译：欧洲公共卫生新闻*总统专栏* eupha办公室专栏 - eupha 1992-2012 *来自世界卫生组织欧洲健康老龄化的世界卫生组织区域总监欧洲：赋予更多人在更高年龄段仍然积极健康*欧洲委员会提出措施更好地保护欧洲人对健康的严重跨界威胁*马耳他2012年度2012年度欧洲公共卫生会议：全包公共卫生，Portomaso，St Julian的，马耳他，2012年11月8日至10日

New drugs and indications in 2012 Sluggish progress, timid measures to protect patients

摘要

著录项

相似文献

相关主题

期刊订阅